Literature DB >> 7995621

Beta-adrenergic neuroeffector mechanisms in cardiac hypertrophy of renin transgenic rats.

M Böhm1, M Moll, B Schmid, M Paul, D Ganten, M Castellano, E Erdmann.   

Abstract

We studied neuroeffector defects in hypertrophied myocardium of hypertensive transgenic rats harboring the mouse Ren-2d gene. In transgenic rats, epinephrine and neuropeptide Y concentrations were reduced. A heterologous desensitization of adenylyl cyclase was observed, which was accompanied by a downregulation of beta 1-adrenergic receptors, an increase of inhibitory G protein alpha-subunits, and a mildly depressed catalyst activity of adenylyl cyclase, whereas the bioactivity of stimulatory G protein alpha-subunits and beta 2-adrenergic receptors was unchanged. Desensitization of adenylyl cyclase was accompanied by a reduced positive inotropic response to isoproterenol, whereas the effect of Ca2+ was unchanged. We conclude that sympathetic neuroeffector defects occur in transgenic rats similar to those observed in human failing myocardium. These alterations occur in the stage of hypertrophy and could contribute to contractile dysfunction in later stages.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995621     DOI: 10.1161/01.hyp.24.6.653

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Expression of immediate early genes, GATA-4, and Nkx-2.5 in adrenergic-induced cardiac hypertrophy and during regression in adult mice.

Authors:  N Saadane; L Alpert; L E Chalifour
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

2.  Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats.

Authors:  S M Gardiner; J E March; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

Review 3.  Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure.

Authors:  X Wang; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2000-11       Impact factor: 3.396

4.  Activation of IGF-2R stimulates cardiomyocyte hypertrophy in the late gestation sheep fetus.

Authors:  Kimberley C W Wang; Doug A Brooks; Kent L Thornburg; Janna L Morrison
Journal:  J Physiol       Date:  2012-08-28       Impact factor: 5.182

Review 5.  Role of G-proteins in altered beta-adrenergic responsiveness in the failing and hypertrophied myocardium.

Authors:  M Böhm; M Flesch; P Schnabel
Journal:  Basic Res Cardiol       Date:  1996       Impact factor: 17.165

6.  Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.

Authors:  S M Gardiner; J E March; P A Kemp; J J Mullins; T Bennett
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

7.  Reduced troponin I phosphorylation and increased Ca(2+)-dependent ATP-consumption in triton X-skinned fiber preparations from Galphaq overexpressor mice.

Authors:  C Pott; L Willkomm; S Grafweg; B Bölck; G W Dorn; R H G Schwinger; K Brixius
Journal:  Mol Cell Biochem       Date:  2008-05-13       Impact factor: 3.396

8.  Decoupling Between Diastolic Pulmonary Arterial Pressure and Pulmonary Arterial Wedge Pressure at Incremental Left Ventricular Assist Device (LVAD) Speeds Is Associated With Worse Prognosis After LVAD Implantation.

Authors:  Teruhiko Imamura; Gene Kim; Jayant Raikhelkar; Nitasha Sarswat; Sara Kalantari; Bryan Smith; Daniel Rodgers; Ben Chung; Ann Nguyen; Takeyoshi Ota; Tae Song; Colleen Juricek; Valluvan Jeevanandam; Daniel Burkhoff; Gabriel Sayer; Nir Uriel
Journal:  J Card Fail       Date:  2018-08-10       Impact factor: 5.712

Review 9.  Rodent models of cardiopulmonary disease: their potential applicability in studies of air pollutant susceptibility.

Authors:  U P Kodavanti; D L Costa; P A Bromberg
Journal:  Environ Health Perspect       Date:  1998-02       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.